Background-Trials investigating efficacy of disease management programs (DMP) in heart failure reported contradictory results. Features rendering specific interventions successful are often ill defined. We evaluated the mode of action and effects of a nurse-coordinated DMP (HeartNetCare-HF, HNC). Methods and Results-Patients hospitalized for systolic heart failure were randomly assigned to HNC or usual care (UC). Besides telephone-based monitoring and education, HNC addressed individual problems raised by patients, pursued networking of health care providers and provided training for caregivers. End points were time to death or rehospitalization (combined primary), heart failure symptoms, and quality of life (SF-36). Of 1007 consecutive patients, 715 were randomly assigned (HNC: nϭ352; UC: nϭ363; age, 69Ϯ12 years; 29% female; 40% New York Heart Association class III-IV). Within 180 days, 130 HNC and 137 UC patients reached the primary end point (hazard ratio, 1.02; 95% confidence interval, 0.81-1.30; Pϭ0.89), since more HNC patients were readmitted. Overall, 32 HNC and 52 UC patients died (1 UC patient and 4 HNC patients after dropout); thus, uncensored hazard ratio was 0.62 (0.40 -0.96; Pϭ0.03). HNC patients improved more regarding New York Heart Association class (Pϭ0.05), physical functioning (Pϭ0.03), and physical health component (Pϭ0.03). Except for HNC, health care utilization was comparable between groups. However, HNC patients requested counseling for noncardiac problems even more frequently than for cardiovascular or heart-failure-related issues. Conclusions-The primary end point of this study was neutral. However, mortality risk and surrogates of well-being improved significantly. Quantitative assessment of patient requirements suggested that besides (tele)monitoring individualized care considering also noncardiac problems should be integrated in efforts to achieve more sustainable improvement in heart failure outcomes. Clinical Trial Registration-URL: http://www. controlled-trials.com. Unique identifier: ISRCTN23325295. (Circ Heart Fail. 2012;5:25-35.)
H eart failure is a major cause of death and hospitalization and is associated with extensive morbidity and impaired quality of life. Although multiple drug-and device-related therapies have improved outcomes, the prognosis of heart failure patients has remained grim. [1] [2] [3] Large surveys from Europe 4,5 and the United States 6 indicate that implementation of evidence-based therapies 7, 8 is fragmentary, although guideline adherence improves survival. 9 Multidisciplinary disease management programs (DMP) may bridge the gap between existing therapeutic options and the realities of clinical practice. Since the landmark study by Rich et al, 10 the
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weight of evidence from meta-analyses regarding the impact of such interventions on survival and hospitalization rates [11] [12] [13] [14] [15] has paved their way into current treatment guidelines, 7, 8 although success has not been consistent throughout. 16 -18 Recommendations regarding basic elements of DMP have been published, 7, 8, 19 but prediction of efficacy has remained difficult. Intervention details are usually not provided, which limits reproducibility, and performance characteristics of DMP in individual subjects have never been reported in detail. Thus far, neither larger-scale implementation of promising DMP outside clinical trials nor sustainable reimbursement strategies have been achieved.
The Interdisciplinary Network for Heart Failure (INH) study developed and evaluated in a randomized, controlled trial a nurse-coordinated DMP (HeartNetCare-HF, HNC). The program comprises patient monitoring and education in a collaborative approach involving skilled nurses, general practitioners, and cardiologists and training and supervision for caregivers. During nurse-driven telephone contacts, standardized questions cover cardiac monitoring. Inquiries about general health and well-being allow patients to raise individual problems. Written intervention templates ensure that all nurses pursue monitoring and education in a comparable manner. As part of the INH study protocol, nurses were instructed to document all patient contacts in detail. We hypothesized that compared with usual care (UC), HNC would have a favorable impact on time to death or rehospitalization (combined primary end point) and various prespecified secondary end points in patients discharged from hospital after cardiac decompensation, who represent a well-defined high-risk target population. 20 We further assumed that the study would serve to clarify the mode of action of the program and individual patient requirements, thus providing a rational basis for more targeted health care strategies in heart failure.
Methods

Setting and Study Design
A multidisciplinary team developed the intervention, based on established elements 8, 19 and shaped to patient needs. 21 Further, a protocol for specialist nurse training and supervision was devised, and a hospital-based call and care center interlacing patients' medical and social networks was installed at the Würzburg University Hospital (Figure 1 ).
The INH study was designed as an open, randomized, 2-armed, parallel-group, multicenter trial. Patients were recruited at 9 hospitals in Bavaria and Baden-Württemberg (see online-only Data Supplement Appendix). Follow-up was centralized and performed after 180 days. Approval was obtained from all responsible ethics committees. The trial complied with the Declaration of Helsinki, and Good Clinical Practice and was preregistered at www.controlled-trials.com (ISRCTN23325295).
Patients
Patients age Ն18 years were eligible when hospitalized with signs and symptoms of decompensated heart failure (dyspnea at rest/ minimal exercise plus at least 1 of the following: raised jugular venous pressure, peripheral edema, third heart sound, or pulmonary congestion [clinical or chest radiography]) and had a left ventricular ejection fraction (LVEF) Յ40% (echocardiography) at random assignment. Exclusion criteria included only new-onset structural heart disease, logistic or health reasons precluding participation in telephone-based interventions, and lack of written consent. Mentally or physically disabled patients with family assistance to follow the protocol were also eligible.
Recruitment and Random Assignment
At all study sites, study physicians were instructed to consecutively report demographics, New York Heart Association (NYHA) class, and LVEF of eligible subjects. This triggered visits from a specialist nurse who invited study participation, explained trial details, and obtained consent. Patients were randomly assigned 1:1 to either HNC or UC, using sealed envelopes. Central computer-generated block random assignment was used (strata: age [Ͼ70 versus Յ70 years], sex, and type of outpatient care [cardiologist versus general practitioner (GP)]).
Postdischarge Care
Usual Care
Patients in UC underwent standard postdischarge planning, which typically included treatment plans, comprehensive discharge letters, and fixed appointments with GPs or cardiologists within 7-14 days. No restrictions were placed on outpatient care, and patients were urged to ensure that providers always documented type and extent of all health care utilization in their INH patient pass.
HeartNetCare-HF
Patients receiving the intervention underwent HNC on top of UC. INH personnel ensured availability of electronic balances and blood pressure gauges at patients' homes. Patients' GPs received written information on the study and were invited to cooperate.
HNC included the following elements: (1) in-hospital face-to-face contact between specialist nurse, patient, and relatives to explain the intervention, practice supervision of blood pressure, heart rate and symptoms, and provide participants with teaching materials and self-monitoring schemes; (2) telephone-based structured monitoring using a standardized 19-item questionnaire addressing indicators of worsening heart failure, other cardiac symptoms, medication, health care utilization, state of mood, and general health and well-being; (3) uptitration of heart failure medication in cooperation with GPs, where possible, and teaching of patients regarding adjustment of diuretics; (4) needs-adjusted specialist care, which nurses coordinated with patients' physician(s); (5) measures for appropriate education and supervision of interveners to ensure high intervention quality (see online-only Data Supplement Part I for details). All nurses were trained in telephone skills, received supervision by a cardiologist (weekly) and a psychologist (bimonthly), and had unrestricted access to their supervisor for questions.
After weekly contacts during the first month, intervention frequency was individualized according to NYHA class at discharge (weekly or fortnightly in NYHA classes III and IV, monthly in NYHA classes I and II), but also patients' individual needs. After major treatment changes, reassessment calls were scheduled as required. Nurses used dedicated contact logs for written documentation of module(s) executed, issues requiring counseling, and actions taken. Recommended duration of telephone contacts was 10 -15 minutes. Treatment goals and forthcoming contacts were jointly fixed by patient and nurse. Emergency telephone access to INH team members and outpatient facilities were available to HNC patients.
Data Collection and Follow-Up
Before discharge, patients underwent standardized evaluation including medical history, physical status, blood chemistry, 12-lead ECG, echocardiography, pulmonary function testing, and generic quality of life (Short Form 36 Health Survey, SF-36). 22 An identical check followed in the INH outpatient clinics after 180 days. Physicians performing the follow-up examination were blinded to patients' initial NYHA class. Patients unable to attend underwent telephonebased follow-up. Health care utilization was extracted from patient passes and reconfirmed by comparison with GP records. Number, duration, and causes of readmissions were verified from discharge letters. Every effort was made to clarify the cause of death, based on hospital records, death certificates, and reports from relatives and physicians. An independent committee adjudicated the end points (see online-only Data Supplement Appendix), blinded to treatment assignment. Because more patients withdrew consent in HNC, potential bias by informative dropout was considered. Life status at day 180 was therefore ascertained in dropouts and reported as uncensored survival data.
End Points
The primary end point was a composite of time to all-cause death or rehospitalization. Prespecified secondary efficacy measures included cardiovascular and all-cause death or hospitalization separately; time to, number, and duration of readmissions; number of patient days alive and not hospitalized; and changes in NYHA class, heart failure medication, cardiac function, and generic quality of life.
Nurses assessed patient compliance, using a summary score (range, 0 -100%) from patients' answers to the START Module during the second and the last contact. "Compliance" thus reflects the nurses' estimate of patients' adherence to self-monitoring and pharmacotherapy. Compliance was not assessed in UC because respective questions were considered potential interventions by themselves.
Biometrical Assumptions and Data Analysis
Based on literature, 23, 24 we assumed a conservative 180-day event rate (all-cause death or rehospitalization) of 30% in UC and a relative risk reduction of 30% in HNC. Assuming a 10% dropout-rate, 700 patients were required to detect this difference, with a power of 0.80 and a 2-sided ␣ of 0.05. Data were analyzed according to intention to treat, and uncensored survival data are reported. The primary hypothesis was tested by log-rank testing. To account for stratification factors and potential confounders, hazard ratios (HR) with 95% confidence intervals (CI) were calculated by Cox proportional hazard regression. Time alive and out of hospital was estimated from extended Kaplan-Meier analyses 25 with standard errors computed by the bootstrap method. All other prespecified quantitative outcomes were assessed by analysis of covariance, adjusting for the baseline value, sex, and age. To test the effect of HNC on NYHA functional class, ordinal logistic regression was performed with NYHA class at follow-up adjusted for baseline NYHA class, and odds ratios (OR) with 95% CIs were reported. Descriptive statistics including independent t test, 2 test, and Fisher exact test were used as appropriate to characterize details of the HNC application.
All probability values are 2-sided. Probability values Յ0.05 were considered statistically significant. Commercial software was used (SPSS 15.0.1; SPSS Inc, Chicago, IL).
Results
Between March 1, 2004, and August 31, 2007, 1007 patients were screened. Of these, 715 (71%) were randomly assigned to either UC (nϭ363) or HNC (nϭ352). Random assignment across predefined strata was successful. Reasons for nonrandomization as given in Figure 2 included severe cognitive dysfunction, Alzheimer's disease, insufficient command of German language, distant residence, lack of telephone access, death before random assignment, or severe noncardiac disorders precluding execution of HNC (eg, deafness). Compared with participants, non-randomly assigned patients were more often female (40% versus 29%, Pϭ0.001), older (75Ϯ11 versus 68Ϯ12 years; PϽ0.001), and more often in NYHA classes III to IV (53% versus 40%; PϽ0.001). LVEF was comparable (30Ϯ7 versus 30Ϯ8; Pϭ0.84). During follow-up, 22 UC and 45 HNC patients withdrew consent (Pϭ0.003); 65 UC and 42 HNC patients underwent a follow-up assessment by telephone. No patient was lost to follow-up.
Patient Baseline Characteristics
Baseline characteristics were comparable in both groups ( Table 1 ). The majority of participants were 70 years or older and had multiple comorbidities. Stratification variables and other baseline characteristics were balanced between groups.
Primary Outcome, Death, and Hospitalization
Outcomes are detailed in Table 2 . The primary end point was reached in 130 HNC (37%) versus 138 UC patients (38%, Figure 3A ). Death occurred more often in UC and rehospitalization slightly more often in HNC. Thus, the composite outcome was comparable (HR, 1.02; 95% CI, 0.81, 1.30; Pϭ0.89).
Overall, 32 (9%) HNC and 52 (14%) UC patients died (HR, 0.62; 0.40 -0.96; Pϭ0.03; Figure 3B ). Five of these deaths occurred after dropout (HNC: nϭ4, UC: nϭ1 One hundred nineteen patients (34%) were rehospitalized at least once in HNC and 112 (31%) in UC (HR, 1.15; 0.89 -1.49; Pϭ0.28; Figure 3C ). As Table 2 indicates, favorable trends toward later, less frequent, and shorter second readmissions and a calculated overall gain of time alive and out of hospital (ϩ4.6 days per patient; Ϫ1.4 to ϩ10.6 days; Pϭ0.13) were observed in the HNC arm.
Heart Failure Severity, Medication, and Quality of Life
Clinical evaluation at 180 days demonstrated also more favorable results regarding NYHA class (Pϭ0.05), uptitra- NYHA indicates New York Heart Association; CABG, coronary artery bypass graft; PCI, percutaneous coronary intervention; ICD, implantable cardioverterdefibrillator; ACEi, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker; and SF-36, Short Form 36 Health Survey.
*Heart rate from the ECG. †Definition of comorbidities: atrial fibrillation from the ECG; hypertension as sitting blood pressure Ͼ140/90 mm Hg or previous history of hypertension; chronic obstructive pulmonary disease as either requiring bronchiolytic treatment or newly diagnosed according to Global Initiative for Chronic Obstructive Lung Disease criteria 26 ; anemia (World Health Organization criteria) as hemoglobin Ͻ12 g/dL in women, Ͻ13 g/dL in men 27 ; and renal dysfunction as estimated glomerular filtration rate Ͻ60 mL/min/1.73 m 2 . 28 ‡Heart failure was treated regarding substance classes, but mean daily equivalence doses of ␤-blockers and ACEi/ARB were only 36% and 43% respectively, of target doses recommended in treatment guidelines. 7, 8 Angermann et al Changing Outcomes in Heart Failure: INH Study 
Application Flow and Performance Characteristics of HNC
Of 352 patients randomly assigned to HNC, 7 died and 16 withdrew consent before the first contact. Thus, 329 subjects received at least 1 intervention. In these, 4057 nurse-and 57 patient-driven telephone contacts (involving 30 patients) took place. Average duration of telephone contacts was 12.5 minutes (95% CI, 11.9 -13.1), corresponding to 2.3 calls (2.1-2.4) and 27.6 minutes (25.7-29.5) per patient-month alive, out of hospital, and under observation. Nurses were instructed to respond to every problem raised by the patients, either immediately or after consultation with a physician. Appropriateness of nurse activities was randomly checked by INH cardiologists during supervision sessions. Table 3 lists nurse activities within the patients' medical and social networks, proportions of patients receiving each HNC module, and average application frequencies in patients receiving a module at least once. Figure 4A depicts absolute and relative frequencies of different nurse actions within the patients' medical and social networks. GP interactions concerned appointments and collaborative patient care. Interactions regarding visits to specialists pertained to cardiologists (44%) but also rehabilitation specialists (20%), surgeons (7%), dentists (6%), rheumatologists (5%), and other disciplines. Direct communication with relatives and friends represented the most frequent nurse activity in this area. Figure 4B shows absolute and relative frequencies of HNC monitoring and educational modules performed by the nurses and of questions raised by patients regarding medical problems. Within the standardized HNC program, the START module pursuing monitoring and various educational modules were routinely applied. Together with individualized advice on risk prevention, these applications amounted to 55% of the topics addressed during follow-up (see onlineonly Data Supplement Part II for details).
Optimizing cardiac pharmacotherapy was a principal task of the nurses. Detailed analysis of respective events exemplifies the complexities of HNC: Of the intervened patients, 84% received repeatedly general advice and education on drugs including self-adjustment of diuretics. In 34%, nurses 
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explicitly suggested either dosage increases of diuretics for significant sudden weight gain or, in stable patients, tentative dose decreases. Uptitration of heart failure medication was achieved in 60%, but downtitration for symptomatic hypotension or bradycardia occurred also (15%). Discussion of noncardiac therapy included, for example, vitamin K antagonists, nonsteroidal antiphlogistics, and potential drug side effects (55%). Further, nurses helped patients to attain nonpharmacological treatments, for example, physiotherapy (9%). Figure 4C details patients' questions on medical problems, which corresponded to 31% of all topics discussed during follow-up (3835 events): Among the general cardiovascular problems, blood pressure (hypotension or hypertension) was most frequently addressed (66% of the patients). Complaints related to heart failure concerned peripheral edema (47%), dyspnea (36%), vertigo (29%), and tiredness (26%). Remarkably, the largest proportion of questions, 37% (1425 events) related to noncardiac problems: Gastroenterological issues including nutrition were brought up at least once by 44% of the patients, musculoskeletal problems and diseases by 31%, neuropsychiatric disorders including depression and cognitive dysfunction by 37%, and nephrological problems including fluid balance by 22%. Questions regarding less common conditions related, for example, to pulmonary problems (20%), diabetes (9%), or anemia (4%). Although counseling for typical angina or chest pain was not uncommonly requested (23%), advice for noncardiac discomfort, for exam-ple, musculoskeletal (21%) or gastrointestinal (5%) pain or headache (4%) was sought even more often.
Patient Compliance
In HNC, compliance among participants remaining in the study was high both at baseline and follow-up (85Ϯ17% and 84Ϯ19%, respectively). Patients who later dropped out had lower compliance (70Ϯ27%).
Physician Contacts
Across the entire study population, mean contact frequencies with GPs (home and office visits) were 13.5Ϯ10.6 in HNC and 12.9Ϯ11.1 in UC, respectively (Pϭ0.46). Mean numbers of visits to cardiologists were 0.7Ϯ2.3 and 0.7Ϯ2.6 per patient in HNC and UC, respectively (Pϭ0.86), and of visits to other specialists, 1.3Ϯ5.4 and 2.1Ϯ9.9, respectively (Pϭ0.17). In HNC, this included also specialist care arranged by the INH team. Average numbers of contacts per patientmonth alive, out of hospital, and under observation were 2.4Ϯ1.8 versus 2.4Ϯ2.1 (GP, Pϭ0.82), 0.1Ϯ0.4 versus 0.1Ϯ0.4 (cardiologists, Pϭ0.88), and 0.2Ϯ0.9 versus 0.4Ϯ1.7 (other specialists, Pϭ0.12) in HNC and UC, respectively.
Discussion
In this randomized, controlled trial involving patients hospitalized for decompensated heart failure, HNC did not reduce the primary combined end point of time to either all-cause death or rehospitalization. Whereas the dominant event of the composite, rehospitalization, tended to be more frequent in HNC, a 38% reduction in all-cause mortality risk (32 patients in HNC versus 52 in UC) was observed. Adequate early readmissions might have prevented fatalities, thus contributing to lower mortality rates in HNC patients. Although the absolute numbers of deaths were relatively small, we consider this result as substantive and promising because it proved consistent with various other prespecified secondary end points also representing important heart failure treatment goals 7, 8 : Significantly greater improvement of NYHA class and psychometric parameters indicated that HNC patients also enjoyed a superior quality of life. Our data further emphasize the need for consideration of noncardiac problems in heart failure and encourage collaborative care models shaped according to individual requirements to improve outcomes. Notably, the more favorable results in intervened patients materialized despite similar intensity of health care utilization and frequency of interventional procedures including device therapy in both groups.
Throughout the entire follow-up period, standardized monitoring based on the START module (see online-only Data Supplement Part I) ascertained persistently high compliance with self-monitoring and drug adherence. In contrast, a recent telemonitoring study, using a telephone-based voice response system without structured personal contacts, reported much lower acceptance because after 180 days, only 86% of participants made any calls and only 55% made the requested minimum of 3 calls per week. 29 Nonadherence may hence have contributed to the disappointing results of this study. Our results indicate that by HNC, a much larger proportion of the heart failure population might be kept in the program long term.
Remarkably, HNC improved secondary end points in patients treated well regarding guideline-mandated substance classes. 7, 8 Because dosage increases in heart failure medication achieved during follow-up were only modest, improved drug adherence rather than drug uptitration might have been the most crucial HNC effect in this respect. Because good compliance was documented in HNC patients, fairly regular intake of heart failure medication can be assumed. In contrast, especially the elderly are under UC conditions inclined to reduce or stop treatment initiated during hospitalization, since nonadherence rates of 30 -60% to drugs and of 30 -80% to nonpharmacological treatment recommendations were reported in the literature. 30 The telephone-based HNC intervention substituted face-toface contacts except for an initial personal encounter. This saved patients from having to attend outpatient services, facilitated specialist care also in subjects otherwise unable to participate for reasons of infirmity, resources or geographical distance, and reached patients at home. Quantitative evaluation of nurse activities within the medical network demonstrated frequent interactions and collaboration of different health care providers. Moreover, direct regular communication between nurses and the patients' social network improved knowledge, selfempowerment and coping strategies within families and strengthened compliance with therapeutic modifications.
Comorbidities observed in our study population resembled those in heart failure registries, 9 and mortality rates were much higher than in most drug trials in which such conditions often constitute exclusion criteria. 31 Correspondingly, more than 80% of our patients sought advise for noncardiac even more frequently than for cardiovascular conditions. Counseling was requested for numerous problems known to also impact on quality of life and other outcomes, for example, depression and cognitive impairment, renal or pulmonary dysfunction, diabetes, anemia, and various types of pain. This is important because it demonstrates objective needs of this population that comprehensive care models must integrate with specific surveillance to account for the complex facets of the heart failure syndrome as well as the physical problems of multimorbidity and old age. Consequently, the training for specialized personnel must be shaped to provide such skills.
Frequency and content of counseling regarding pharmacotherapy varied widely, which illustrates why technically based response systems could never adequately meet respective patient needs. Although a predefined HNC goal, uptitration of heart failure medication was not always possible, and various clinical situations even demanded downtitration. Assistance in fluid management was often required, although nurses regularly taught self-adjustment of diuretics in HNC patients. Thus, a highly individualized approach including consideration of drugs for comorbidities and their potential side effects or interactions proved necessary in this type of patient.
Earlier reviews failed to provide definite conclusions about the general value of DMP in heart failure though demonstrating the potential for benefits in principle. [11] [12] [13] [14] [15] Heterogeneity in outcomes even of large, well-designed trials 17, 23, 24, 32 probably resulted from the methodological and clinical diversity of length of follow-up, type of intervention, and in particular characteristics of participants. Although in stable low-risk patients an intervention facilitating timely treatment of worsening heart failure improved short-term 23 and even long-term rehospitalization rates, 33 similar interventions in high-risk populations comparable to ours reduced fatalities but not hospital readmissions. 17, 18 Further, intervention quality appeared of relevance. Thus, decentralized delivery of care without prespecified supervision of caregivers and lack of collaboration between different health care providers as in the COACH trial 17 might perhaps explain comparatively smaller beneficial effects in this study.
Our study satisfies several quality criteria rarely met in earlier DM research: It considered patient preferences as identified in a previous INH survey, 21 used precisely characterized intervention modules, measured health care utilization, recruited a welldefined study population, and accounted for needs of the interveners. The protocol scheduled prospective documentation of the actual application flow, where in a collaborative approach, skilled nurses interacted with patients and their medical and social networks. This approach provided, for the first time, precise information on patients' actual requirements. Collection bias was avoided by comprehensive cross-check of the patient passes with other health care documentation in both study arms. All end points were adjudicated by an independent committee blinded to treatment assignment.
Other telemonitoring techniques have been proposed that use remote-access technology by means of external, wearable, or implantable electronic devices and facilitate frequent or even continuous monitoring. 34 Although 2 recent large, well-designed trials 29, 35 using such tools as an exclusive intervention failed to improve outcomes, this does not preclude their potentially beneficial role as an adjunct to patient surveillance. In support of this concept, both monthly nursebased telephone support alone or combined with daily electronic transmission of vital parameters reduced total mortality, and only daily telemonitoring on top of the telephone support also reduced hospitalization frequency. 24 Thus, novel technologies may serve heart failure patients best if integrated in a program encompassing different health care services and empowering patients to assume responsibility and actively participate in the management of their disease. Our data complement this concept because they provide unequivocal evidence that a comprehensive strategy of heart failure care also must address coexisting noncardiac problems.
Some limitations must be mentioned. Although all-cause mortality risk and surrogates of well-being improved significantly, the primary composite end point of our study was neutral. Although encouraging, these results call for better definition of relevance and value of each of the modules used to find in populations with different levels of risk in each case the most appropriate combination of human and technologybased resources. Further, the relatively short follow-up period in the INH study precludes extrapolation to longer-term outcomes. We covered, however, the most vulnerable period after hospitalization, 20 and many patients gained immediate benefit. Another limitation regards blinding: Although patients were unaware of the trial hypotheses, placebo effects might have influenced outcomes. However, we did not encounter such bias in our analyses. Of further concern is the generalizability of results, but, compared with other trials, 17, 29 the number of nonparticipants was small. Because patients with preserved LVEF were excluded from this trial, our findings cannot be extrapolated to this large population. Last, intervention and follow-up were centralized and performed by a highly motivated team. Reproducibility of our results remains thus to be proven at other institutions, including nonacademic hospitals. Detailed documentation should, however, enable motivated personnel to attain comparable success.
In conclusion, we developed and evaluated a structured collaborative DMP for patients hospitalized for systolic heart failure. After 180 days, the primary composite end point was neutral. However, mortality risk and important surrogates of patient well-being were improved. Analysis of the application flow in individual subjects provided deeper understanding of patient requirements and highlighted the importance of noncardiac comorbidities and complications in the heart failure population. Our findings encourage health care strategies aiming to align different care modules in multidisciplinary collaborative programs and integrating novel (tele)monitoring technologies with comprehensive individualized care for both cardiac and noncardiac problems, in efforts to achieve more sustainable improvement in heart failure outcomes.
